These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

69 related items for PubMed ID: 1961692

  • 1. Light-dark phase differences in behavioral effects of moclobemide in rats.
    Górka Z, Zajaczkowski W.
    Pol J Pharmacol Pharm; 1991; 43(3):177-86. PubMed ID: 1961692
    [Abstract] [Full Text] [Related]

  • 2. Some central effects of brofaromine given repeatedly are phase-dependent.
    Górka Z, Zajaczkowski W.
    Pol J Pharmacol Pharm; 1990; 42(4):313-20. PubMed ID: 2097592
    [Abstract] [Full Text] [Related]

  • 3. The effects of single and repeated administration of MAO inhibitors on acoustic startle response in rats.
    Zajaczkowski W, Górka Z.
    Pol J Pharmacol; 1993; 45(2):157-66. PubMed ID: 8401768
    [Abstract] [Full Text] [Related]

  • 4. Effects of repeated treatment with antidepressant drugs on the 24 hour behavior in the light-dark synchronized mice.
    Górka Z, Maj J.
    Pol J Pharmacol Pharm; 1986; 38(5-6):493-9. PubMed ID: 3575167
    [Abstract] [Full Text] [Related]

  • 5. Comparison of behavioral effects of moclobemide and deprenyl during forced swimming.
    Ferigolo M, Barros HM, Marquardt AR, Tannhauser M.
    Pharmacol Biochem Behav; 1998 Jun; 60(2):431-7. PubMed ID: 9632226
    [Abstract] [Full Text] [Related]

  • 6. The effects of moclobemide on the yohimbine-induced anxiogenic action in the elevated plus-maze.
    Eroğlu L, Güven O.
    Pharmacol Res; 1998 Feb; 37(2):137-43. PubMed ID: 9572069
    [Abstract] [Full Text] [Related]

  • 7. The rate of behavioral tolerance development to repeated lipopolysaccharide treatments depends upon the time of injection during the light-dark cycle: a multivariable examination of locomotor activity.
    Franklin AE, Engeland CG, Kavaliers M, Ossenkopp KP.
    Behav Brain Res; 2007 Jun 18; 180(2):161-73. PubMed ID: 17433456
    [Abstract] [Full Text] [Related]

  • 8. Anxiolytic and memory improving effects of moclobemide.
    Nowakowska E, Chodera A, Kus K, Rybakowski J.
    Arzneimittelforschung; 1998 Jun 18; 48(6):625-8. PubMed ID: 9689417
    [Abstract] [Full Text] [Related]

  • 9. [Comparison of the new MAO-A inhibitors moclobemide, brofaromine and toloxatone with tranylcypromine in an animal experiment: significance for clinical practice].
    Da Prada M, Keller HH, Kettler R.
    Psychiatr Prax; 1989 Aug 18; 16 Suppl 1():18-24. PubMed ID: 2587673
    [Abstract] [Full Text] [Related]

  • 10. cAMP-dependent phosphorylation system after short and long-term administration of moclobemide.
    Mori S, Zanardi R, Popoli M, Garbini S, Brunello N, Smeraldi E, Racagni G, Perez J.
    J Psychiatr Res; 1998 Aug 18; 32(2):111-5. PubMed ID: 9694007
    [Abstract] [Full Text] [Related]

  • 11. An activity indicator of acute withdrawal depends on amphetamine dose in rats.
    White W, White IM.
    Physiol Behav; 2006 Feb 28; 87(2):368-76. PubMed ID: 16364380
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.
    Burkard WP, Bonetti EP, Da Prada M, Martin JR, Polc P, Schaffner R, Scherschlicht R, Hefti F, Müller RK, Wyss PC.
    J Pharmacol Exp Ther; 1989 Jan 28; 248(1):391-9. PubMed ID: 2913284
    [Abstract] [Full Text] [Related]

  • 13. Moclobemide effects on prolactin plasma levels in healthy individuals: the hormonal increase induced by a single dose is maintained during a 4-week period of drug intake.
    Juruena MF, Pires ML, Calil HM.
    Int Clin Psychopharmacol; 1997 Nov 28; 12(6):317-21. PubMed ID: 9547133
    [Abstract] [Full Text] [Related]

  • 14. Time-dependent effects of antidepressant drugs on the low dose of apomorphine-induced locomotor hypoactivity in rats.
    Dziedzicka-Wasylewska M, Rogóz Z.
    Pol J Pharmacol; 1997 Nov 28; 49(5):337-43. PubMed ID: 9566033
    [Abstract] [Full Text] [Related]

  • 15. Differential effects of alcohol consumption and withdrawal on circadian temperature and activity rhythms in Sprague-Dawley, Lewis, and Fischer male and female rats.
    Taylor AN, Tio DL, Bando JK, Romeo HE, Prolo P.
    Alcohol Clin Exp Res; 2006 Mar 28; 30(3):438-47. PubMed ID: 16499484
    [Abstract] [Full Text] [Related]

  • 16. The advent of a new generation of monoamine oxidase inhibitor antidepressants: pharmacologic studies with moclobemide and brofaromine.
    Lavian G, Finberg JP, Youdim MB.
    Clin Neuropharmacol; 1993 Mar 28; 16 Suppl 2():S1-7. PubMed ID: 8313392
    [Abstract] [Full Text] [Related]

  • 17. In vivo characterization of T-794, a novel reversible inhibitor of monoamine oxidase-A, as an antidepressant with a wide safety margin.
    Kato M, Katayama T, Iwata H, Yamamura M, Matsuoka Y, Narita H.
    J Pharmacol Exp Ther; 1998 Mar 28; 284(3):983-90. PubMed ID: 9495858
    [Abstract] [Full Text] [Related]

  • 18. SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. I. Psychopharmacological profile in rodents.
    Worms P, Kan JP, Wermuth CG, Roncucci R, Bizière K.
    J Pharmacol Exp Ther; 1987 Jan 28; 240(1):241-50. PubMed ID: 3100770
    [Abstract] [Full Text] [Related]

  • 19. [The effect of pyrazidol and inkazan on the rotation behavior of rats].
    Mashkovskiĭ MD, Bogdanov MB, Bondarenko NA.
    Farmakol Toksikol; 1989 Jan 28; 52(6):29-32. PubMed ID: 2625142
    [Abstract] [Full Text] [Related]

  • 20. The effect of scheduled forced wheel activity on body weight in male F344 rats undergoing chronic circadian desynchronization.
    Tsai LL, Tsai YC.
    Int J Obes (Lond); 2007 Sep 28; 31(9):1368-77. PubMed ID: 17356527
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.